Navigation Links
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Date:10/29/2008

quity 1,190.3 1,227.0

-------- ---------

Total liabilities and shareholders' equity 4,327.5 4,330.1

-------- ---------

Unaudited US GAAP results for the three and nine months to September 30, 2008

Consolidated Statements of Operations

3 months 3 months 9 months 9 months

to to to to

September September September September

30, 30, 30, 30,

2008 2007(1) 2008 2007(1)

$M $M $M $M

Continuing operations -------- -------- -------- --------

Revenues:

Product sales 712.5 543.1 2,049.9 1,508.8

Royalties 60.8 61.9 190.7 185.4

Other revenues 5.3 3.7 15.8 17.6

-------- ------- -------- --------

Total revenues 778.6 608.7 2,256.4 1,711.8

-------- ------- -------- --------

Costs and expenses:

Cost of product sales(1) (2) (3) 84.2 83.4 317.4 224.7

Research and development(1) (3) 127.1 181.4 394.4 365.7

Selling, general and administrative(1)

(2) 320.4 328.4 1,083.7 847.5

Integration costs 7.5 - 7.5 1.3

Gain on sale of product rights (4.0) (7.1) (20.7) (12.1)

In-process R&D char
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
3. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
4. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
5. Consumers Looking to Sustainable Food Production to Feed Global Population
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
8. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
9. Ventria Expands Lactoferrin Production
10. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
11. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera...he first patient in a randomized Phase 2B study of...-stage development for multiple oncology indicatio...mized Phase 2 Study of the X-Linked Inhibitor of A...ation with High-dose Cytarabine and Idarubicin in ...
(Date:11/18/2009)..., , DAVIS, Calif., Nov. 18 M...overy, development and commercialization of effect...t products, announced that it has been named an IC...ates, oldest and largest national angel investing ...performance leading to rewarding results for all s...
(Date:11/18/2009)..., , RICHMOND, Calif., Nov. 18 /PRNewswire-...SGMO ) announced today that data from the Universi...safety study of Sangamo,s zinc finger nuclease (ZF...vertently and prematurely disclosed on the interne...t the University of Pennsylvania School of Medicin...
(Date:11/18/2009)..., , MISSISSAUGA, ON, Nov. 18 /PRNewswire-Fir...SX: YM), a life sciences product development compa...o of promising cancer-related products at various ... a study evaluating nimotuzumab were presented tod...r Targets and Cancer Therapeutics conference in Bo...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...ion reagents , , D.J. Lowrie Jr. ,Depart...,University of Cincinnati College of Medicine, Cin...n cell lines is enhanced by the use of,liposome-...fficiency of green,fluorescent protein into huma...,transfection reagent and LipofectAMINE ,re...
...ter cell lines for signal transduction pathway rea...Mary Buchanan ,John Bauer Chao-Feng Zheng ,St... ,HLR-CREB, HLR-Elk1, and HLR-cJun, cell line...s that converge at the transcription,factors CRE...eature constitutive,expression of the GAL4-CREB,...
...ignal transduction pathways , , Li Xu Tim Sa...s, Inc. , Enhancer elements are the convergent p... pathways. For simple, rapid and convenient assess..., Stratagene has designed the PathDetect ,in vi...ms. Each of the cis-reporter,plasmids contains t...
Other Biology Technology:Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 2Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 3Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 4Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 2Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 3Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 4Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 5Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion,Transactivators 6Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 2Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 3Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 4
(Date:11/19/2009)..., WALL, N.J., Nov. 19 BI...I), a leader in wireless public safety and finger-...d that the Special Shareholder Meeting held today ...se a quorum was not present. ,, (Logo: http://...,, While an impressive 99.3% of the 35 million ...
(Date:11/19/2009)...by Penn State,s Ross Hardison, T. Ming Chu Profess...n a large step toward unraveling how regulatory pr...ing development and growth. Working with collabora... at Children,s Hospital of Philadelphia, they focu...ng red blood cells (erythrocytes). These cells con...
(Date:11/19/2009)...ler, University of Cincinnati professor of paleont...and co-author Michael Foote of the University of C... of Science with their paper, "Epicontinental Se...s Extinction and Origination." , For many years,...tory of biodiversity have focused on charting the ...
Breaking Biology News(10 mins):BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Media Alert 3A July 10 Run Miles for Special Smiles 47691 1Media Alert 3A July 10 Run Miles for Special Smiles 47691 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 1Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 3ViroPharma to Present at Two June Healthcare Conferences 12426 1ViroPharma to Present at Two June Healthcare Conferences 12426 2
... LA JOLLA, Calif., April 9, 2009Scientists at Bur...the University of California San Diego (UC San Die...hat transplanted pancreatic precursor cells are pr...n polytetrafluorethylene (PTFE). The study, which ...s, was published online on April 8 in the journal ...
... Scientists have developed a new approach for sur...d by critical cell signaling pathways and regulate...rch, published by Cell Press in the April 10th iss...regulation of a previously uncharacterized protein...in cancer cell invasion. , Many cancers, includin...
... In the classic waterfall illusion, if you stare ...iod of time, stationary objects like rocks appea...that this phenomenon, called motion aftereffect, o...n our tactile perception, and that these senses ac... you feel the world can actually change how you se...
Other Biology News:Device protects transplanted pancreatic cells from the immune system 2New method for detection of phosphoproteins reveals regulator of melanoma invasion 2MIT: How you feel the world impacts how you see it 2
adenosine 5'-O-(3-thiotriphosphate), BODIPY FL conjugated/tagged from Molecular Probes (Invitrogen)
...n offers precise 96 and 384-well transfers in a sm...00ul disposable tips, the 96 channel parallel pipe...on across a volume range from 1-200uls. The six po...ble indexing into 384 well plates, and one positio...
...rays contain 60 rabbit tissue samples arrayed on S...tains 4 unstained slides and 1 hematoxylin and eos...ide contains 15 different tissues from 4 rabbit or...e. Each tissue sample (or core) is 1.5 mm in diame...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, Floppy Disk from PerkinElmer
Biology Products: